<DOC>
	<DOCNO>NCT00884000</DOCNO>
	<brief_summary>This trial set compare Zomacton Genotropin treatment growth hormone deficiency child . The child treat 1 year . Half patient treat Genotropin half Zomacton . During time dose every day parent home evening . There 138 patient trial age 3 age 11 . The patient treat growth hormone patient must prove growth hormone deficiency , show specific test perform trial local clinic trial . During time treatment patient come visit clinic every 3 month . At visit height measure , blood sample take , physical examination perform question health ask . At 2 time trial hand x-ray take measure bone age . At end trial patient stop treatment continue one market product available treat growth hormone deficiency .</brief_summary>
	<brief_title>A Study Zomacton Children With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Signed informed consent 2 . Children age ≤3yrs old 10 yrs girl 11 yr boys 3 . Idiopathic growth hormone deficiency confirm prescreening period standard GH stimulation test ( define peak level &lt; 10ng/ml pr low required country specific board ( ) 4 . Height SDS &lt; 2 SD ref value CA 5 . Height velocity SDSCA ≤ 0 SD ref value lease 6 month prior prescreening 6 . Height record least 6 month 18 month prescreening 7 . The difference CABA≥ 1 8 . A positive locally perform GH stimulation test ( define peak plasma level &lt; 9ng/ml low require country specific board ( ) ) prior prescreening 1 . BA 9 yrs girl 10 yr boys 2 . Puberty Tanner stage &gt; 1 3 . Weight &lt; 12 Kg screen 4 . Any prior treatment GH 5 . Closed epiphysis 6 . Any diagnosed suspect syndrome ( e.g . Silver Russell , Turner 's seckel syndrome ) possibly could affect growth 7 . Any diagnosed suspected endocrine metabolic disorder 8 . Any diagnosed suspect sever chronic disease 9 . Clinical sign dysmorphic feature , malformation mental retardation 10 . Growth failure due disorder 11 . Previous present use drug could interfere GH treatment ( e.g . steroid ) 12 . Diagnosed malignant disease 13 . Any abnormal CS lab result require investigation 14 . Receipt investigational drug within last 28 day precede screening longer consider possible influence outcome current trial 15 . Any knowledge hypersensitivity somatropin excipients Zomacton Genotropin</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>